Find Academic Supervisors

Erika FERRARIView profile

Associate Professor

• Inorganic Medicinal Chemistry
• Metal-Based Drugs
• Metal Trafficking in vitro
• +7 more

Erika Ferrari is an Associate Professor at the Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia. Her research focuses on inorganic medicinal chemistry , particularly in metal-based drug development , metal trafficking studies , and advanced NMR techniques for complex matrices. She leads projects on inorganic drug delivery systems and theranostic agents , with significant work on curcumin derivatives and bioactive glasses. Current projects include development of 68Ga-labeled radiotracers for Alzheimer's and cancer imaging Environmental applications in soil organic matter analysis and microalgae-based biostimulants Research Highlights: Her work bridges coordination chemistry with pharmaceutical applications , focusing on metal chelation therapy , anticancer agents , and green synthesis methods . Recent publications emphasize mesoporous silica carriers and stabilized curcumin analogs . Teaching: She instructs courses in General and Inorganic Chemistry , Industrial Inorganic Chemistry , and Coordination Compound Chemistry , emphasizing stoichiometry , chemical equilibria , and laboratory safety .

• Reproductive Health
• Obstetrics
• Gynecology
• +3 more

Elena Soukhov, MD, is a Lecturer at the University of Maryland School of Medicine, affiliated with the Department of Obstetrics, Gynecology and Reproductive Sciences. Her clinical focus centers on labor and delivery, with specialized research interests in reproductive endocrinology, including endometriosis, PCOS, recurrent pregnancy loss, and IVF optimization. University of Toronto (BS in Human Biology and Psychology, Minor in Jewish Studies, 2014) Medical School for International Health, Ben Gurion University (MD, 2019) University of Maryland Medical Center (OBGYN Residency, 2023) Dr. Soukhov's research integrates reproductive health with clinical excellence, emphasizing patient-centered care and technical innovation. Her publications span reproductive medicine, neuroscience, and endocrinology, reflecting interdisciplinary expertise. Student Teacher Award (2022) Gold Humanism Award (2019) Clinical Excellence Award (2019) Research Award (2017) She actively contributes to teaching and community engagement, speaking Hebrew, Russian, and English fluently.

Theresa MurphyView profile

Professor

• Immunology
• Dendritic Cell Biology
• Lymphocyte Development
• +4 more

Theresa Murphy serves as a Professor in the Department of Pathology & Immunology at Washington University School of Medicine, specializing in immunological mechanisms with particular emphasis on dendritic cell biology and immune response regulation. Her work bridges fundamental immunology with translational applications in tumor immunology and infectious disease. Her academic foundation includes: BS, Summa Cum Laude, Chemistry, University of Arizona, Tucson, AZ (1978) PhD, Johns Hopkins University School of Medicine, Baltimore, MD (1983) Postdoctoral Training under J. Thomas August, Johns Hopkins University School of Medicine (1983-1984) Dr. Murphy's research program investigates dendritic cell development and lymphocyte subset differentiation, focusing on how immune responses are selected against pathogens and the mechanisms of dendritic cell-mediated tumor rejection. Her work integrates cellular immunology with molecular genetics to uncover fundamental principles of immune regulation, with significant implications for cancer immunotherapy and vaccine development. Current projects explore transcriptional control of immune cell differentiation through enhancer elements and superenhancers. Her publication portfolio demonstrates consistent contributions to dendritic cell biology, monocyte development, and transcriptional regulation, revealing critical roles for factors like Irf8 and C/EBPα in immune cell lineage decisions. The work spans immunology, molecular genetics, and cell biology, with recurring themes in enhancer function and cell-type-specific gene expression. Notable recognitions include: Phi Beta Kappa (1978) Summa Cum Laude (1978) American Institute of Chemists Award for Scholastic Achievement (1978) American Institute of Chemists Award for Scholastic Achievement (1977) Dr. Murphy maintains a collaborative research program within the Immunobiology Division, working closely with Dr. Kenneth Murphy. Her laboratory receives support through institutional funding and likely NIH mechanisms common to established immunology researchers, though specific grants aren't detailed in available sources. She contributes to graduate education through the Washington University Graduate Program in Molecular Genetics and Genomics. As a core member of the Immunobiology Division, she participates in interdisciplinary initiatives studying immune cell development and function, contributing expertise in dendritic cell biology to the broader research ecosystem of the Department of Pathology & Immunology.

Keith MillerView profile

Associate Professor

• Cancer Immunotherapy
• Tissue Engineering
• Biochemistry
• +3 more

Dr. Keith Miller serves as an Associate Professor in the Department of Biochemistry and Chemistry at the University of Mount Union, where he teaches General Chemistry II, Introduction to Biochemistry, Medicinal Chemistry, Advanced Biochemistry Laboratory, and an innovative Honors board game design seminar. His pedagogical approach emphasizes sparking scientific curiosity through real-world connections and primary literature analysis to cultivate critical thinking and lifelong learning habits. His research program focuses on cancer immunotherapy and tissue engineering, specifically developing liposome-based drug delivery systems that target immune cells like macrophages and neutrophils. By manipulating liposome properties including size, charge, and surface chemistry, his laboratory optimizes therapeutic delivery for cancer treatment and immune modulation, bridging biochemistry, immunology, and pharmaceutical sciences. Dr. Miller's publication record reveals dual expertise: educational research on flipped classrooms and literature-based curricula, and biomedical studies on nanoparticle therapeutics and immune cell targeting. His educational innovations enhance student engagement across biochemistry education, while his scientific work advances liposome engineering for precise drug delivery in oncology. No scientific awards were documented in the provided materials. As a dedicated mentor, Dr. Miller supervises undergraduate research projects within his laboratory and encourages students to explore departmental opportunities spanning: Alzheimer’s disease mechanisms Cancer therapeutics development Novel antibiotic discovery Stroke treatment pharmaceuticals Metal toxicity investigations Solar cell and battery technology Regular research journal clubs foster critical analysis of scientific literature among students and faculty, with department-wide open-door policies facilitating academic collaboration. The department maintains a vibrant research ecosystem where Dr. Miller's current projects investigate liposome targeting specificity and macrophage response modulation, contributing to next-generation immunotherapies through interdisciplinary student-faculty collaboration.

Mark GomelskyView profile

Professor

• Molecular Biology
• Microbiology
• Bacterial Signal Transduction
• +8 more

Mark Gomelsky is a Professor in the Department of Molecular Biology at the University of Wyoming. He earned his Ph.D. in Biological Sciences from the Institute for Genetics and Selection of Industrial Microorganisms in Moscow, Russia, and completed post-doctoral training at Institut Pasteur in Paris and the University of Texas Medical School in Houston. His research spans bacterial signal transduction, photoreception, and synthetic biology, with a focus on cyclic di-GMP (c-di-GMP) signaling, Listeria-plant biofilms, and engineered bacterial systems for medical applications. Education: Ph.D. in Biological Sciences (1991), Institute for Genetics and Selection of Industrial Microorganisms, Moscow, Russia Post-doctoral training, Institut Pasteur, Paris, France Post-doctoral training, University of Texas Medical School, Houston, USA Dr. Gomelsky’s research has pioneered c-di-GMP signaling in bacteria, revealing its role in biofilm formation and virulence. His lab discovered novel photoreceptors and engineered near-infrared light-activated enzymes for optogenetic applications, including diabetes and neuronal regulation. Key projects include: Listeria-plant biofilms: Investigating exopolysaccharide synthesis and contamination prevention on fresh produce. Listerial bactodrones: Developing genetically modified Listeria strains for targeted cancer therapy via tumor microenvironment activation. Metabolic engineering: Manipulating Rhodobacter sphaeroides for hydrogen production and asymmetric bacterial cell division. His publications emphasize bacterial signaling, biofilm dynamics, and optogenetic tools. Over 90 research papers reflect his expertise in molecular microbiology and synthetic biology. Awards include AAAS Fellowship (2016) and the Jack Kenney Award (2016). Lab members include postdocs, Ph.D. students, and research assistants, with collaborations across microbiology, synthetic biology, and medical applications.

Kostas G. LyketsosView profile

Professor

• Alzheimer's Disease
• Dementia
• Biomarkers
• +5 more

Kostas G. Lyketsos is a world-renowned Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University , where he directs the Department of Psychiatry and Behavioral Sciences at Johns Hopkins Bayview, the Richman Family Precision Medicine Center of Excellence in Alzheimer’s Disease , and the Memory and Alzheimer’s Treatment Center . A dual clinician-scientist, he combines active patient care with cutting-edge research on Alzheimer’s disease and related dementias (ADRD). Research Focus: Neuropsychiatric symptoms in AD and dementia Biomarker development for early detection Precision medicine approaches to treatment Innovative clinical trial design Community-based dementia care models Scientific Contributions: With over 450 peer-reviewed publications (76,000+ citations, h-index 149), Dr. Lyketsos ranks #13 globally in Geriatrics (2021 Stanford study). His work spans epidemiology, neuroimaging, and therapeutic interventions, particularly targeting agitation and psychosis in dementia patients. Scientific Honors: 2022 Argo Award from the President of Greece William Proxmire Award for Alzheimer's Research Distinguished Scientist, American Association for Geriatric Psychiatry Jeanne and William E. Weinberg Award Professional Leadership: As Associate Editor of American Journal of Psychiatry and Deputy Editor of International Psychogeriatrics , he shapes field-wide discourse. His team actively develops interventions like the Tailored Activity Program for dementia care.

Michel LinderView profile

Professor

• Physical chemistry of lipids
• Nano-vectorization
• Food emulsions
• +5 more

Michel Linder is a Full Professor at the University of Lorraine, affiliated with the National School of Agronomy and Food Industries (ENSAIA) and the Nutrition and Food Sciences (NSA) Department. His research focuses on the physical chemistry of lipids , nano-vectorization for bioactive delivery, and industrial process optimization using experimental design methodologies. Key research areas include: Lipid self-assembly at interfaces Controlled release of biomolecules Enzymatic protein extraction from marine/vegetal sources Polyunsaturated fatty acid enrichment via enzymatic-membrane processes Valorization of waste oils for non-food applications Development of edible oleogels He has received the prestigious CHEVREUL Medal (2023) for contributions to lipid science. His publications highlight extensive work in nanoliposomal systems for drug delivery, food emulsions , and green chemistry approaches. Collaborations span Hokkaido University, UC Davis, Monash University, and CNRS institutions.

• Diabetes Research
• Biophysics
• Bioengineering
• +4 more

Richard Benninger, PhD, serves as Assistant Professor at the University of Colorado Anschutz Medical Campus School of Medicine with joint appointments in Bioengineering and Pediatrics. He directs the Advanced Light Microscopy core facility and leads a multidisciplinary research program focused on diabetes mechanisms. Education: PhD, Imperial College of Science, Technology and Medicine (2006) Research Focus: The Benninger lab applies engineering principles to study pancreatic islets of Langerhans, investigating systems biophysics in diabetes, gap junction plasticity , cell heterogeneity , and advanced imaging techniques . Their work bridges optical microscopy , ultrasound imaging , and biophysical modeling to develop diabetes diagnostics and therapeutics targeting hormone release mechanisms. Publication Trends: Analysis of 15 recent publications reveals consistent focus on islet multicellular dynamics (73% of articles), gap junction regulation (60%), and imaging technology development (47%). Temporal trends show increasing emphasis on human islet studies (2017-2020) and translational applications for type 1 diabetes diagnostics. Scientific Awards: No awards were documented in the provided materials. Academic Service: Benninger actively contributes to diabetes research through the American Diabetes Association and Biophysical Society memberships. The text contains no information regarding graduate student mentorship or grant funding. Research Infrastructure: The Benninger lab operates as a collaborative engineering-medicine unit centered around the Advanced Light Microscopy core. Their technical capabilities integrate two-photon microscopy , calcium imaging , and computational modeling to analyze islet function across molecular, cellular, and tissue scales in both mouse and human models.

• Organic Chemistry
• Medicinal Chemistry
• Drug Discovery
• +7 more

Dr. Fabrizio Pertusati is a Lecturer at the School of Chemistry, Cardiff University, with expertise in organic and medicinal chemistry. He holds an MSc in Physical Organic Chemistry from the University of Turin and a PhD in asymmetric organic chemistry from Cardiff School of Chemistry. His academic journey includes postdoctoral training at Emory University and in the laboratory of Nobel laureate Prof. George Olah at the University of Southern California. Dr. Pertusati's research focuses on the design and synthesis of small molecules as therapeutics against rare diseases (including congenital disorder of glycosylation, Niemann-Pick, Cystinosis, and GNE myopathy), infectious diseases, and antifungal drug discovery. His key expertise areas include organofluorine chemistry, organophosphorus chemistry, carbohydrate chemistry, and the design and synthesis of phosphate/phosphonate prodrugs of carbohydrate scaffolds. His recent publications demonstrate a strong focus on nucleoside prodrug technologies (particularly ProTide technology), with applications in antiviral therapy, anticancer agents, and treatment of rare metabolic disorders. His work often involves interdisciplinary collaborations with researchers specializing in lysosomal storage diseases, biofilm formation, and antimicrobial resistance. Dr. Pertusati serves as a reviewer for numerous prestigious journals including Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, and Organic Letters. He has also been a reviewer for MRC-fellowship grants and was a member of the Scientific Advisory Board of Ichorion Therapeutics (2017-2018). His teaching portfolio includes courses on industrial applications of biocatalysis, techniques in drug discovery, drug targets, drug development from laboratory to clinic, and introduction to drug development.

• Immunology
• Exercise Physiology
• Angiogenic Cells
• +5 more

Mark Ross is a Lecturer in the School of Applied Sciences at Edinburgh Napier University with research expertise at the intersection of exercise physiology, immunology, and cardiovascular health. His work focuses on angiogenic cells, particularly endothelial progenitor cells and angiogenic T-cells, and their role in vascular repair mechanisms. Dr. Ross's primary research interests include the cellular mechanisms of vascular repair following exercise, with emphasis on how aging, type 1 diabetes, and cardiovascular disease affect these processes. His work examines exercise-induced mobilization of angiogenic cells across different populations, the impact of exercise intensity and duration on immune cell responses, and the relationship between endothelial function and clinical conditions like diabetes and cancer. His publication record shows a consistent trajectory from 2017 to 2025, evolving from foundational work on angiogenic cells in aging to more recent investigations of ultra-endurance exercise effects on T-cell populations. This progression demonstrates expanding scope while maintaining core focus on exercise immunology and vascular health across diverse clinical populations. Dr. Ross has successfully secured multiple research grants including a £58,079 award from the ENU Development Trust for research on exercise training to attenuate chemotherapy-induced cardiotoxicity, a £19,951 grant from the Diabetes Research & Wellness Foundation for studying residual beta cell function and exercise in type 1 diabetes, and smaller grants from the Scottish Funding Council and British Association of Sport and Exercise Sciences. As an academic supervisor, he served as Director of Studies for PhD research on angiogenic T-cells and endothelial progenitor cells (2011-2016), working closely with Prof Geraint Florida-James and Dr Eva Malone. His research collaborations extend across the Biomedical Science Research Group and Sports, Exercise and Health Science Research Group within the university.

Melville VaughanView profile

Professor

• Cell Biology
• Molecular Biology
• Wound Healing
• +3 more

Melville Vaughan is a Professor in the Department of Biology at the University of Central Oklahoma since 2012. He specializes in studying myofibroblast biology in diseases like Dupuytren's Contracture, wound healing, and fibrosis using in vitro models. His research often involves collaborations with engineers and clinicians to develop biomaterials and imaging techniques for tissue repair. University of Central Oklahoma: Professor (2012–present), Assistant Chair (2017–20), Interim Chair (2020–22). Education: B.S. in Botany (1987, University of Oklahoma), Ph.D. in Anatomical Sciences/Cell Biology (1998, University of Oklahoma Health Science Center), Postdoctoral Research Fellow (1999–2004, UT Southwestern Medical Center). Vaughan’s research focuses on myofibroblast differentiation and contraction in fibrocontractive diseases. His team uses optical coherence tomography and 2D/3D cell culture models to study fibroblast behavior under treatments like near-infrared lasers, chitosan derivatives, and nanofibers. Collaborations include Dr. Gang Xu (Engineering), Dr. Christina Hendrickson (Cancer Biology), and Dr. Morshed Khandaker (Biomedical Engineering). His recent publications (2016–2023) highlight work on wound healing biomaterials, nanofiber scaffolds for bone regeneration, and laser effects on fibroblast contraction. Articles emphasize interdisciplinary approaches combining cell biology with materials science and mechanical engineering. Vaughan integrates research into undergraduate and graduate education via CUREs (Course-based Undergraduate Research Experiences), particularly in Cell Biology Laboratory (BIO2211), where students contribute to preliminary studies for his lab's projects.

Jefferson KnightView profile

Professor

• Protein-Membrane Interactions
• Single-Molecule Biophysics
• Insulin Secretion Mechanisms
• +3 more

Jefferson Knight is a Professor in the Department of Chemistry at the University of Colorado Denver's College of Liberal Arts and Sciences. He serves as Faculty Director of the Office of Undergraduate Research and Creative Activities, demonstrating his commitment to student research development. His academic appointments span both teaching and research, with a focus on biochemistry and biophysical chemistry. Dr. Knight earned his B.S. in Chemistry from the University of North Carolina in 2000, followed by a Ph.D. in Pharmacology from Yale University in 2006. His postdoctoral training was completed in the laboratory of Prof. Joseph Falke at the University of Colorado Boulder, where he developed single-molecule fluorescence microscopy methods for studying protein-membrane interactions. His research program focuses on molecular interactions of proteins and lipid membranes, particularly those involved in insulin secretion. His laboratory investigates how membrane-targeting proteins dock to lipid membranes through specific recognition of lipid headgroups, electrostatic interactions, hydrophobic insertion, and protein-protein interactions. A major emphasis is understanding how defects in these processes may contribute to type II diabetes. His lab employs a diverse toolkit including fluorescence resonance energy transfer, single-molecule fluorescence microscopy, protein purification, and various spectroscopic techniques. Analysis of his recent publications reveals a consistent focus on synaptotagmins and synaptotagmin-like proteins (Slps), with particular attention to their C2 domains and membrane binding mechanisms. His work spans fundamental biophysical characterization to educational research, demonstrating both depth in his specialty and breadth in application. Recent trends show increasing collaboration with other researchers and expansion into diabetes-related mechanisms. Dr. Knight actively mentors undergraduate and graduate students in his laboratory, with numerous students listed as co-authors on publications. His educational contributions include developing innovative biochemistry curricula that integrate threshold concepts with information literacy skills. His lab provides research opportunities for students across multiple disciplines including Chemistry, Biochemistry, Biology, and Engineering. The Knight Laboratory maintains active collaborations within CU Denver and with external institutions, creating a vibrant research environment focused on understanding the molecular mechanisms of regulated exocytosis and membrane trafficking. His work bridges fundamental biophysics with physiological relevance to diabetes research.

• Colon Cancer Pathogenesis
• Cancer Chemoprevention
• Gastrointestinal Disorders
• +7 more

Dr. Bruce Bissonnette is an Associate Professor at the University of Chicago Pritzker School of Medicine , specializing in Gastroenterology within the Department of Medicine. His clinical expertise spans diagnosis and management of gastrointestinal disorders such as Barrett’s esophagus Inflammatory Bowel Disease Colorectal Cancer Peptic Ulcer Disease and related conditions. Education & Training: Internship: Philadelphia Naval Hospital (1976) Residency: Hospital of the University of Pennsylvania (1980) Fellowship: Hospital of the University of Pennsylvania (1981) Clinical Staff Fellow: NIADDK, NIH (1984) Faculty: University of Chicago (1990–Present) Research Interests focus on colon cancer pathogenesis and chemoprevention , particularly the role of Western diets, fish oil, and signaling pathways (ADAM17-EGFR, CXCL12-CXCR4) using Animal Models Human Tissue Cultures Colonic Organoids In Vitro Systems His lab is developing a liquid biopsy for early CRC detection via 5-hydroxymethylcytosine biomarkers with Dr. Chuan He and Dr. Wei Zhang. He also investigates Ythdf1 in immune-mediated tumor suppression and the pro-renin receptor (Atp6ap2) in tumor suppression via vitamin D and RAS inhibition, collaborating with Dr. Yan Chun Li. Publication Trends span biochemistry , molecular biology , and cancer research , emphasizing Signal Transduction miRNA Regulation VDR-EGFR Cross-Talk Proteomic Interactions with over 15 high-impact studies since 2014.

• Statistical Genetics
• Computational Genomics
• Genetic Heterogeneity
• +7 more

Andrew Dahl is an Assistant Professor in the Department of Medicine-Genetic Medicine at the University of Chicago. His research focuses on developing computational methods to discover and characterize genetic heterogeneity in complex diseases, with applications to asthma, major depressive disorder, single cell omics, and cross-population portability of genetic predictions. Dr. Dahl received his education from the following institutions: PhD in Genomic Medicine and Statistics from Oxford University (2016) MS in Statistics from University of Chicago (2012) Honors BS in Mathematics from University of Chicago (2012) BA in Economics from University of Chicago (2012) Dr. Dahl's research centers on computational approaches to discover and characterize context-specific genetic effects on complex disorders. His lab develops methods for gene-environment interaction, gene-gene interaction, and identifying genetic subtypes of disease. The group particularly focuses on applications to asthma, major depressive disorder, single cell omics, and cross-population portability of genetic predictions, with the long-term goal of advancing equitable precision treatment by embracing the full diversity of human contexts. Analysis of Dr. Dahl's publications reveals a strong focus on statistical genetics methodology, particularly in understanding genetic heterogeneity, disease subtyping, and context-specific heritability. His work spans multiple domains including psychiatric genetics, functional genomics, and evolutionary biology, with a consistent emphasis on developing robust computational methods to address challenges in complex trait analysis. Dr. Dahl has received the following scientific awards: Clarendon Scholarship from Oxford University (2012-2016) Phi Beta Kappa from University of Chicago (2012) Dr. Dahl leads the Dahl Lab at the University of Chicago, which focuses on statistical genetics methodology. The lab develops computational methods to discover and characterize genetic heterogeneity in complex diseases. They are actively recruiting students and postdocs from the Human Genetics (HG) and Genetic Genomics Sciences Bridge (GGSB) PhD programs. Current research projects include new clustering algorithms for finding biologically meaningful subtypes, statistical interaction tests to validate subtypes, and applications in psychiatric, metabolic, and immune domains using rich phenotypes and large biobanks.

• RNA modifications
• Diabetes
• Aging
• +5 more

Dario De Jesus is an Assistant Professor in the Section of Genetic Medicine at the University of Chicago . His research focuses on RNA modifications, particularly m6A methylation, in the context of diabetes and aging. Supported by NIH R00DK135927 and K99DK135927 awards, he investigates how RNA modifications govern pancreatic beta-cell function and systemic metabolism. His work bridges molecular biology, cell biology, and metabolism, with significant contributions to understanding epigenetic mechanisms in metabolic diseases. NIH R00DK135927 : 2025-2028 NIH K99DK135927 : 2023-2025 His research has been recognized by the American Diabetes Association and European Association for the Study of Diabetes , and he has published extensively in journals like Nature Cell Biology and Cell Metabolism . His publications frequently address m6A methylation, insulin resistance, and beta-cell biology, with high citation metrics reflecting their impact. Dr. De Jesus is also an active mentor, combining his research pursuits with teaching and academic training. Prior to his current position, he held roles at Harvard Medical School and Joslin Diabetes Center, developing expertise in molecular metabolism and epigenetics.